Table of Contents Author Guidelines Submit a Manuscript
Journal of Nutrition and Metabolism
Volume 2011, Article ID 983038, 8 pages
http://dx.doi.org/10.1155/2011/983038
Research Article

Chemopreventive Potential of Synergy1 and Soybean in Reducing Azoxymethane-Induced Aberrant Crypt Foci in Fisher 344 Male Rats

1Nutritional Biochemistry and Carcinogenesis Laboratory, Department of Food and Animal Sciences, Alabama A&M University, P.O. Box 1628, Normal, AL 35762, USA
2Department of Chemistry, Alabama A&M University, Normal, AL 35762, USA

Received 15 November 2009; Revised 22 June 2010; Accepted 16 January 2011

Academic Editor: Michael M. Müller

Copyright © 2011 V. P. Gourineni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Cancer Society, Facts, Figures and Statistics, ACS, Atlanta, Ga, USA, 2008.
  2. N. S. Painter and D. P. Burkitt, “Diverticular disease of the colon: a deficiency disease of Western civilization,” The British Medical Journal, vol. 2, no. 759, pp. 450–454, 1971. View at Google Scholar · View at Scopus
  3. B. R. Goldin and S. L. Gorbach, “The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer,” Journal of the National Cancer Institute, vol. 57, no. 2, pp. 371–375, 1976. View at Google Scholar · View at Scopus
  4. S. L. Gorbach, “The intestinal microflora and its colon cancer connection,” Infection, vol. 10, no. 6, pp. 379–384, 1982. View at Google Scholar · View at Scopus
  5. S. E. McGarr, J. M. Ridlon, and P. B. Hylemon, “Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature,” Journal of Clinical Gastroenterology, vol. 39, no. 2, pp. 98–109, 2005. View at Google Scholar · View at Scopus
  6. B. Boursi and N. Arber, “Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention,” Current Pharmaceutical Design, vol. 13, no. 22, pp. 2274–2282, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. B. S. Reddy, “Chemoprevention of colon cancer by dietary administration of naturally-occurring and related synthetic agents,” Advances in Experimental Medicine and Biology, vol. 400, pp. 931–936, 1997. View at Google Scholar · View at Scopus
  8. A. S. Tsao, E. S. Kim, and W. K. Hong, “Chemoprevention of cancer,” Ca-A Cancer Journal for Clinicians, vol. 54, no. 3, pp. 150–180, 2004. View at Google Scholar · View at Scopus
  9. A. Umar, J. L. Viner, E. Richmond, W. F. Anderson, and E. T. Hawk, “Chemoprevention of colorectal carcinogenesis,” International Journal of Clinical Oncology, vol. 7, no. 1, pp. 2–26, 2002. View at Google Scholar · View at Scopus
  10. D. P. Burkitt, “Epidemiology of large bowel disease: the role of fibre,” Proceedings of the Nutrition Society, vol. 32, no. 3, pp. 145–149, 1973. View at Google Scholar · View at Scopus
  11. B. Pool-Zobel, J. Van Loo, I. Rowland, and M. B. Roberfroid, “Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer,” British Journal of Nutrition, vol. 87, no. 2, pp. S273–S281, 2002. View at Google Scholar · View at Scopus
  12. M. Verghese, D. R. Rao, C. B. Chawan, L. L. Williams, and L. Shackelford, “Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at the promotion stage in young Fisher 344 rats,” Journal of Nutrition, vol. 132, no. 9, pp. 2809–2813, 2002. View at Google Scholar · View at Scopus
  13. M. Verghese, L. T. Walker, L. Shackelford, and C. B. Chawan, “Inhibitory effects of nondigestible carbohydrates of different chain lengths on azoxymethane-induced aberrant crypt foci in Fisher 344 rats,” Nutrition Research, vol. 25, no. 9, pp. 859–868, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. B. L. Pool-Zobel, “Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data,” British Journal of Nutrition, vol. 93, pp. S73–S90, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Atkinson, C. L. Frankenfeld, and J. W. Lampe, “Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health,” Experimental Biology and Medicine, vol. 230, no. 3, pp. 155–170, 2005. View at Google Scholar · View at Scopus
  16. A. O. Omoni and R. E. Aluko, “Soybean foods and their benefits: potential mechanisms of action,” Nutrition Reviews, vol. 63, no. 8, pp. 272–283, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. S. M. Heinonen, A. Hoikkala, K. Wähälä, and H. Adlercreutz, “Metabolism of the soy isoflavones daidzein, genistein and glycitein in human subjects. Identification of new metabolites having an intact isoflavonoid skeleton,” Journal of Steroid Biochemistry and Molecular Biology, vol. 87, no. 4-5, pp. 285–299, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. K. D. R. Setchell, “Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones,” American Journal of Clinical Nutrition, vol. 68, no. 6, pp. 1333S–1346S, 1998. View at Google Scholar · View at Scopus
  19. K. D. R. Setchell and A. Cassidy, “Dietary isoflavones: biological effects and relevance to human health,” Journal of Nutrition, vol. 129, no. 3, pp. 758S–767S, 1999. View at Google Scholar · View at Scopus
  20. J. M. W. Wong and D. J. A. Jenkins, “Carbohydrate digestibility and metabolic effects,” Journal of Nutrition, vol. 137, no. 11, pp. 2539S–2546S, 2007. View at Google Scholar · View at Scopus
  21. J. P. Yuan, J. H. Wang, and X. Liu, “Metabolism of dietary soy isoflavones to equol by human intestinal microflora—implications for health,” Molecular Nutrition and Food Research, vol. 51, no. 7, pp. 765–781, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. K. D. R. Setchell, N. M. Brown, and E. Lydeking-Olsen, “The clinical importance of the metabolite equol—A clue to the effectiveness of soy and its isoflavones,” Journal of Nutrition, vol. 132, no. 12, pp. 3577–3584, 2002. View at Google Scholar · View at Scopus
  23. J. H. Mitchell, P. T. Gardner, D. B. McPhail, P. C. Morrice, A. R. Collins, and G. G. Duthie, “Antioxidant efficacy of phytoestrogens in chemical and biological model systems,” Archives of Biochemistry and Biophysics, vol. 360, no. 1, pp. 142–148, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Rimbach, S. De Pascual-Teresa, B. A. Ewins et al., “Antioxidant and free radical scavenging activity of isoflavone metabolites,” Xenobiotica, vol. 33, no. 9, pp. 913–925, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. T. E. Hedlund, W. U. Johannes, and G. J. Miller, “Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro,” Prostate, vol. 54, no. 1, pp. 68–78, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Liew, J. K. Williams, P. Collins, and K. T. Macleod, “Soy-derived isoflavones exert opposing actions on guinea pig ventricular myocytes,” Journal of Pharmacology and Experimental Therapeutics, vol. 304, no. 3, pp. 985–993, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Srivastava, M. Verma, and D. E. Henson, “Biomarkers for early detection of colon cancer,” Clinical Cancer Research, vol. 7, no. 5, pp. 1118–1126, 2001. View at Google Scholar · View at Scopus
  28. B. Tudek, R. P. Bird, and W. R. Bruce, “Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods,” Cancer Research, vol. 49, no. 5, pp. 1236–1240, 1989. View at Google Scholar · View at Scopus
  29. D. E. Corpet and F. Pierre, “Point: from animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system,” Cancer Epidemiology Biomarkers and Prevention, vol. 12, no. 5, pp. 391–400, 2003. View at Google Scholar · View at Scopus
  30. J. M. Matés, “Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology,” Toxicology, vol. 153, no. 1–3, pp. 83–104, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. L. M. Sanders, C. E. Henderson, M. Y. Hong et al., “An increase in reactive oxygen species by dietary fish oil coupled with the attenuation of antioxidant defenses by dietary pectin enhances rat colonocyte apoptosis,” Journal of Nutrition, vol. 134, no. 12, pp. 3233–3238, 2004. View at Google Scholar · View at Scopus
  32. S. C. Cotton, L. Sharp, J. Little, and N. Brockton, “Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review,” American Journal of Epidemiology, vol. 151, no. 1, pp. 7–32, 2000. View at Google Scholar · View at Scopus
  33. W. H. Habig, M. J. Pabst, and W. B. Jakoby, “Glutathione S transferases. The first enzymatic step in mercapturic acid formation,” The Journal of Biological Chemistry, vol. 249, no. 22, pp. 7130–7139, 1974. View at Google Scholar · View at Scopus
  34. J. M. Matés, C. Pérez-Gómez, and I. Núñez de Castro, “Antioxidant enzymes and human diseases,” Clinical Biochemistry, vol. 32, no. 8, pp. 595–603, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. P. G. Reeves, F. H. Nielsen, and G. C. Fahey, “AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet,” Journal of Nutrition, vol. 123, no. 11, pp. 1939–1951, 1993. View at Google Scholar · View at Scopus
  36. R. P. Bird, “Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings,” Cancer Letters, vol. 37, no. 2, pp. 147–151, 1987. View at Google Scholar · View at Scopus
  37. J. Sedlak and R. H. Lindsay, “Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent,” Analytical Biochemistry, vol. 25, pp. 192–205, 1968. View at Google Scholar · View at Scopus
  38. H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984. View at Google Scholar · View at Scopus
  39. I. Fridovich, “Superoxide dismutases. An adaptation to a paramagnetic gas,” The Journal of Biological Chemistry, vol. 264, no. 14, pp. 7761–7764, 1989. View at Google Scholar · View at Scopus
  40. AACC, Approved Methods, 8th edition, 1984.
  41. J. Boateng, M. Verghese, C. B. Chawan et al., “Red palm oil suppresses the formation of azoxymethane (AOM) induced aberrant crypt foci (ACF) in Fisher 344 male rats,” Food and Chemical Toxicology, vol. 44, no. 10, pp. 1667–1673, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. E. M. Dommels, S. Heemskerk, H. van den Berg, G. M. Alink, P. J. van Bladeren, and B. van Ommen, “Effects of high fat fish oil and high fat corn oil diets on initiation of AOM-induced colonic aberrant crypt foci in male F344 rats,” Food and Chemical Toxicology, vol. 41, no. 12, pp. 1739–1747, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. R. P. Bird and C. K. Good, “The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer,” Toxicology Letters, vol. 112-113, pp. 395–402, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Dolara, G. Caderni, and C. Luceri, “Surrogate endpoint biomarkers for human colon carcinogenesis,” Toxicology Letters, vol. 112-113, pp. 415–420, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. R. G. Stevens, H. Swede, and D. W. Rosenberg, “Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies,” Cancer Letters, vol. 252, no. 2, pp. 171–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Xiao, X. Hao, B. Simi et al., “Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats,” Carcinogenesis, vol. 29, no. 1, pp. 113–119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. B. S. Reddy, A. Rivenson, K. El-Bayoumy, P. Upadhyaya, B. Pittman, and C. V. Rao, “Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets,” Journal of the National Cancer Institute, vol. 89, no. 7, pp. 506–512, 1997. View at Google Scholar · View at Scopus
  48. S. Toden, A. R. Bird, D. L. Topping, and M. A. Conlon, “Differential effects of dietary whey, casein and soya on colonic DNA damage and large bowel SCFA in rats fed diets low and high in resistant starch,” British Journal of Nutrition, vol. 97, no. 3, pp. 535–543, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Jacobsen, M. Poulsen, L. O. Dragsted, G. Ravn-Haren, O. Meyer, and R. H. Lindecrona, “Carbohydrate digestibility predicts colon carcinogenesis in azoxymethane-treated rats,” Nutrition and Cancer, vol. 55, no. 2, pp. 163–170, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Verghese, D. R. Rao, C. B. Chawan, and L. Shackelford, “Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats,” Journal of Nutrition, vol. 132, no. 9, pp. 2804–2808, 2002. View at Google Scholar · View at Scopus
  51. Z. Zduńczyk, J. Juśkiewicz, and I. Estrella, “Cecal parameters of rats fed diets containing grapefruit polyphenols and inulin as single supplements or in a combination,” Nutrition, vol. 22, no. 9, pp. 898–904, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. J. H. Cummings, E. W. Pomare, W. J. Branch, C. P. E. Naylor, and G. T. Macfarlane, “Short chain fatty acids in human large intestine, portal, hepatic and venous blood,” Gut, vol. 28, no. 10, pp. 1221–1227, 1987. View at Google Scholar · View at Scopus
  53. A. P. Femia, C. Luceri, P. Dolara et al., “Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats,” Carcinogenesis, vol. 23, no. 11, pp. 1953–1960, 2002. View at Google Scholar · View at Scopus
  54. V. Coxam, “Current data with inulin-type fructans and calcium, targeting bone health in adults,” Journal of Nutrition, vol. 137, no. 11, pp. 2527S–2533S, 2007. View at Google Scholar · View at Scopus
  55. J. Boateng, M. Verghese, L. Shackelford et al., “Selected fruits reduce azoxymethane (AOM)-induced aberrant crypt foci (ACF) in Fisher 344 male rats,” Food and Chemical Toxicology, vol. 45, no. 5, pp. 725–732, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. M. J. Wargovich, “Diallylsulfide and allylmethylsulfide are uniquely effective among organosulfur compounds in inhibiting CYP2E1 protein in animal models,” Journal of Nutrition, vol. 136, no. 3, pp. 832S–834S, 2006. View at Google Scholar · View at Scopus
  57. M. N. Ebert, A. Klinder, W. H. M. Peters et al., “Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate,” Carcinogenesis, vol. 24, no. 10, pp. 1637–1644, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. B. L. Pool-Zobel, V. Selvaraju, J. Sauer et al., “Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics,” Carcinogenesis, vol. 26, no. 6, pp. 1064–1076, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Sauer, K. K. Richter, and B. L. Pool-Zobel, “Products formed during fermentation of the prebiotic inulin with human gut flora enhance expression of biotransformation genes in human primary colon cells,” British Journal of Nutrition, vol. 97, no. 5, pp. 928–937, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Ohta, M. Uehara, K. Sakai et al., “A combination of dietary fructooligosaccharides and isoflavone conjugates increases femoral bone mineral density and equol production in ovariectomized mice,” Journal of Nutrition, vol. 132, no. 7, pp. 2048–2054, 2002. View at Google Scholar · View at Scopus
  61. D. G. Thiagarajan, M. R. Bennink, L. D. Bourquin, and F. A. Kavas, “Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium,” American Journal of Clinical Nutrition, vol. 68, no. 6, pp. 1394S–1399S, 1998. View at Google Scholar · View at Scopus
  62. J. Raju, “Azoxymethane-induced rat aberrant crypt foci: relevance in studying chemoprevention of colon cancer,” World Journal of Gastroenterology, vol. 14, no. 43, pp. 6632–6635, 2008. View at Publisher · View at Google Scholar · View at Scopus